C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event
Published 2018 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
C/EBPβ deletion in oncogenic Ras skin tumors is a synthetic lethal event
Authors
Keywords
-
Journal
Cell Death & Disease
Volume 9, Issue 11, Pages -
Publisher
Springer Nature America, Inc
Online
2018-10-15
DOI
10.1038/s41419-018-1103-y
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Synthetic lethality and cancer
- (2017) Nigel J. O'Neil et al. NATURE REVIEWS GENETICS
- RAS Synthetic Lethal Screens Revisited: Still Seeking the Elusive Prize?
- (2015) J. Downward CLINICAL CANCER RESEARCH
- Dragging Ras Back in the Ring
- (2014) Andrew G. Stephen et al. CANCER CELL
- ER stress-induced cell death mechanisms
- (2013) Renata Sano et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Caspase-3 feeds back on caspase-8, Bid and XIAP in type I Fas signaling in primary mouse hepatocytes
- (2012) Karine Sá Ferreira et al. APOPTOSIS
- STAR: ultrafast universal RNA-seq aligner
- (2012) Alexander Dobin et al. BIOINFORMATICS
- NIH Image to ImageJ: 25 years of image analysis
- (2012) Caroline A Schneider et al. NATURE METHODS
- Hallmarks of Cancer: The Next Generation
- (2011) Douglas Hanahan et al. CELL
- The CCAAT/enhancer (C/EBP) family of basic-leucine zipper (bZIP) transcription factors is a multifaceted highly-regulated system for gene regulation
- (2011) Junichi Tsukada et al. CYTOKINE
- XIAP-associated factor 1 (XAF1), a novel target of p53, enhances p53-mediated apoptosis via post-translational modification
- (2011) Bing Zou et al. MOLECULAR CARCINOGENESIS
- TNFSF10 (TRAIL), a p53 target gene that mediates p53-dependent cell death
- (2010) Kageaki Kuribayashi et al. CANCER BIOLOGY & THERAPY
- Decreased CCAAT/enhancer binding protein β expression inhibits the growth of glioblastoma cells
- (2010) D. Aguilar-Morante et al. NEUROSCIENCE
- C/EBPα and C/EBPβ Are Required for Sebocyte Differentiation and Stratified Squamous Differentiation in Adult Mouse Skin
- (2010) John S. House et al. PLoS One
- C/EBP regulates transcription factors critical for proliferation and survival of multiple myeloma cells
- (2009) R. Pal et al. BLOOD
- Principles of Cancer Therapy: Oncogene and Non-oncogene Addiction
- (2009) Ji Luo et al. CELL
- C/EBP expression in ALK-positive anaplastic large cell lymphomas is required for cell proliferation and is induced by the STAT3 signaling pathway
- (2009) N. Anastasov et al. HAEMATOLOGICA
- Identification and characterization of the interferon-β-mediated p53 signal pathway in human peripheral blood mononuclear cells
- (2009) Fanglin Zhang et al. IMMUNOLOGY
- Differential Role for c-Rel and C/EBP / in TLR-Mediated Induction of Proinflammatory Cytokines
- (2009) Y.-C. Lu et al. JOURNAL OF IMMUNOLOGY
- CCAAT Enhancer Binding Protein- Regulates Matrix Metalloproteinase-1 Expression in Interleukin-1 -Stimulated A549 Lung Carcinoma Cells
- (2009) D. A. Armstrong et al. MOLECULAR CANCER RESEARCH
- Multi-stage chemical carcinogenesis in mouse skin: Fundamentals and applications
- (2009) Erika L Abel et al. Nature Protocols
- C/EBPβ regulates metastatic gene expression and confers TNF-α resistance to prostate cancer cells
- (2009) Myoung H. Kim et al. PROSTATE
- The identification of C/EBPβ as a transcription factor necessary for the induction of MAPK phosphatase-1 by toll-like receptor-4 ligand
- (2008) Il Je Cho et al. ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS
- C/EBPβ represses p53 to promote cell survival downstream of DNA damage independent of oncogenic Ras and p19Arf
- (2008) S J Ewing et al. CELL DEATH AND DIFFERENTIATION
- Transcriptional role of p53 in interferon-mediated antiviral immunity
- (2008) César Muñoz-Fontela et al. JOURNAL OF EXPERIMENTAL MEDICINE
- Impaired response to GM-CSF and G-CSF, and enhanced apoptosis in C/EBP -deficient hematopoietic cells
- (2007) T. Akagi et al. BLOOD
Publish scientific posters with Peeref
Peeref publishes scientific posters from all research disciplines. Our Diamond Open Access policy means free access to content and no publication fees for authors.
Learn MoreCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now